Decode Shares Up 10 Percent as Bank Upgrades Stock

Mar 08, 2007

NEW YORK (GenomeWeb News) — Shares in Decode Genetics were up 10 percent, or $.35, at $3.87 after the stock was upgraded by an investment bank

Lehman Brothers upgraded the stock to "equal-weight" from "underweight."

Decode yesterday reported that fourth-quarter revenues increased 17 percent as R&D spending rose 4 percent and lossed increased 10 percent.

Breaking News

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.